Literature DB >> 9160487

Non-parametric inference for cumulative incidence functions in competing risks studies.

D Y Lin1.   

Abstract

In the competing risks problem, a useful quantity is the cumulative incidence function, which is the probability of occurrence by time t for a particular type of failure in the presence of other risks. The estimator of this function as given by Kalbfleisch and Prentice is consistent, and, properly normalized, converges weakly to a zero-mean Gaussian process with a covariance function for which a consistent estimator is provided. A resampling technique is developed to approximate the distribution of this process, which enables one to construct confidence bands for the cumulative incidence curve over the entire time span of interest and to perform Kolmogorov-Smirnov type tests for comparing two such curves. An AIDS example is provided.

Entities:  

Mesh:

Year:  1997        PMID: 9160487     DOI: 10.1002/(sici)1097-0258(19970430)16:8<901::aid-sim543>3.0.co;2-m

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  181 in total

1.  Comparing sub-survival functions in a competing risks model.

Authors:  K C Carriere; S C Kochar
Journal:  Lifetime Data Anal       Date:  2000-03       Impact factor: 1.588

2.  Estimation of cumulative incidence functions when the lifetime distributions are uniformly stochastically ordered.

Authors:  Noriah M A Al-Kandari; Emad-Eldin A A Aly; Hammou El Barmi
Journal:  Lifetime Data Anal       Date:  2011-10-25       Impact factor: 1.588

3.  Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.

Authors:  Marcie R Tomblyn; Marian Ewell; Christopher Bredeson; Brad S Kahl; Stacey A Goodman; Mary M Horowitz; Julie M Vose; Robert S Negrin; Ginna G Laport
Journal:  Biol Blood Marrow Transplant       Date:  2010-11-10       Impact factor: 5.742

4.  Bounds on the covariate-time transformation for competing-risks survival analysis.

Authors:  Simon J Bond; J Ewart H Shaw
Journal:  Lifetime Data Anal       Date:  2006-08-18       Impact factor: 1.588

5.  Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies.

Authors:  Waseem Touma; Claudio G Brunstein; Qing Cao; Jeffrey S Miller; Julie Curtsinger; Michael R Verneris; Veronika Bachanova
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-17       Impact factor: 5.742

6.  Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.

Authors:  Jeffrey S Miller; Daniel J Weisdorf; Linda J Burns; Arne Slungaard; John E Wagner; Michael R Verneris; Sarah Cooley; Rosanna Wangen; Susan K Fautsch; Roby Nicklow; Todd Defor; Bruce R Blazar
Journal:  Blood       Date:  2007-06-19       Impact factor: 22.113

7.  Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.

Authors:  Erica Dahl Warlick; Todd E DeFor; Nelli Bejanyan; Shernan Holtan; Margaret MacMillan; Bruce R Blazar; Kathryn Dusenbery; Mukta Arora; Veronika Bachanova; Sarah Cooley; Aleksandr Lazaryan; Philip McGlave; Jeffrey S Miller; Armin Rashidi; Arne Slungaard; Gregory Vercellotti; Celalettin Ustun; Claudio Brunsein; Daniel Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2018-08-01       Impact factor: 5.742

8.  Inference for current leukemia free survival.

Authors:  Leiyan Liu; Brent Logan; John P Klein
Journal:  Lifetime Data Anal       Date:  2008-07-30       Impact factor: 1.588

9.  Summarizing differences in cumulative incidence functions.

Authors:  Mei-Jie Zhang; Jason Fine
Journal:  Stat Med       Date:  2008-10-30       Impact factor: 2.373

10.  Bone Marrow versus Peripheral Blood from Unrelated Donors for Children and Adolescents with Acute Leukemia.

Authors:  Daniel A Keesler; Andrew St Martin; Carmem Bonfim; Adriana Seber; Mei-Jie Zhang; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2018-08-22       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.